Restoration of connexin 40 (Cx40) in renin-producing cells reduces the hypertension of Cx40 null mice

Hypertension

Volumn 63, Issue 6, 2014, Pages 1198-1204

  Gal, Loïc Le ^a   Alonso, Florian ^a   Wagner, Charlotte ^b   Germain, Stéphane ^c   Haefliger, Denise Nardelli ^a   Meda, Paolo ^d   Haefliger, Jacques Antoine ^a,e  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c CNRS   (France)

^d UNIVERSITY OF GENEVA   (Switzerland)

^e Laboratory of Experimental Medicine   (Switzerland)

Author keywords

Aorta; Connexins; Endothelial cells; Hypertension; Kidney; Myocytes; Rennin; Smooth muscle

Indexed keywords

CONNEXIN 37; CONNEXIN 40; ENDOTHELIAL NITRIC OXIDE SYNTHASE; RENIN;

ANIMAL EXPERIMENT; ARTERIOLE; ARTERY WALL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ENDOTHELIUM CELL; HYPERTENSION; MOUSE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RENIN PRODUCING CELL; RENIN RELEASE; SIGNAL TRANSDUCTION; WILD TYPE;

AORTA; CONNEXINS; ENDOTHELIAL CELLS; HYPERTENSION; KIDNEY; MYOCYTES; RENIN; SMOOTH MUSCLE;

ANIMALS; ANTIGENS, CD31; ARTERIOLES; BLOOD PRESSURE; BLOTTING, WESTERN; CONNEXINS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PROMOTER REGIONS, GENETIC; RECEPTOR, TIE-2; RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 84902276702     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.02976     Document Type: Article

References (40)

1. Gerido DA, White TW. Connexin disorders of the ear, skin, and lens. Biochim Biophys Acta. 2004;1662:159-170.
2. Zoidl G, Dermietzel R. Gap junctions in inherited human disease. Pflugers Arch. 2010;460:451-466.
3. Pfenniger A, Wohlwend A, Kwak BR. Mutations in connexin genes and disease. Eur J Clin Invest. 2011;41:103-116.
4. Haefliger JA, Nicod P, Meda P. Contribution of connexins to the function of the vascular wall. Cardiovasc Res. 2004;62:345-356.
5. Kurtz A. Renin release: sites, mechanisms, and control. Annu Rev Physiol. 2011;73:377-399.
6. Bosco D, Haefliger JA, Meda P. Connexins: key mediators of endocrine function. Physiol Rev. 2011;91:1393-1445.
7. Potolicchio I, Cigliola V, Velazquez-Garcia S, Klee P, Valjevac A, Kapic D, Cosovic E, Lepara O, Hadzovic-Dzuvo A, Mornjacovic Z, Meda P. Connexin-dependent signaling in neuro-hormonal systems. Biochim Biophys Acta. 2012;1818:1919-1936.
8. Krattinger N, Capponi A, Mazzolai L, Aubert JF, Caille D, Nicod P, Waeber G, Meda P, Haefliger JA. Connexin40 regulates renin production and blood pressure. Kidney Int. 2007;72:814-822.
9. de Wit C, Roos F, Bolz SS, Kirchhoff S, Krüger O, Willecke K, Pohl U. Impaired conduction of vasodilation along arterioles in connexin 40-deficient mice. Circ Res. 2000;86:649-655.
10. de Wit C, Roos F, Bolz SS, Pohl U. Lack of vascular connexin 40 is associated with hypertension and irregular arteriolar vasomotion. Physiol Genomics. 2003;13:169-177.
11. Wagner C, de Wit C, Kurtz L, Grünberger C, Kurtz A, Schweda F. Connexin40 is essential for the pressure control of renin synthesis and secretion. Circ Res. 2007;100:556-563.
12. Alonso F, Boittin FX, Bény JL, Haefliger JA. Loss of connexin40 is associated with decreased endothelium-dependent relaxations and eNOS levels in the mouse aorta. Am J Physiol Heart Circ Physiol. 2010;299:H1365-H1373.
13. Alonso F, Krattinger N, Mazzolai L, Simon A, Waeber G, Meda P, Haefliger JA. An angiotensin II- and NF-kappaB-dependent mechanism increases connexin 43 in murine arteries targeted by renin-dependent hypertension. Cardiovasc Res. 2010;87:166-176.
14. Pfenniger A, Derouette JP, Verma V, Lin X, Foglia B, Coombs W, Roth I, Satta N, Dunoyer-Geindre S, Sorgen P, Taffet S, Kwak BR, Delmar M. Gap junction protein Cx37 interacts with endothelial nitric oxide synthase in endothelial cells. Arterioscler Thromb Vasc Biol. 2010;30:827-834.
15. Kameritsch P, Pogoda K, Ritter A, Münzing S, Pohl U. Gap junctional communication controls the overall endothelial calcium response to vasoactive agonists. Cardiovasc Res. 2012;93:508-515.
16. Boittin FX, Alonso F, Le Gal L, Allagnat F, Bény JL, Haefliger JA. Connexins and M3 muscarinic receptors contribute to heterogeneous Ca(2+) signaling in mouse aortic endothelium. Cell Physiol Biochem. 2013;31:166-178.
17. Wagner C, Jobs A, Schweda F, Kurtz L, Kurt B, Lopez ML, Gomez RA, van Veen TA, de Wit C, Kurtz A. Selective deletion of Connexin 40 in renin-producing cells impairs renal baroreceptor function and is associated with arterial hypertension. Kidney Int. 2010;78:762-768.
18. Jobs A, Schmidt K, Schmidt VJ, Lübkemeier I, van Veen TA, Kurtz A, Willecke K, de Wit C. Defective Cx40 maintains Cx37 expression but intact Cx40 is crucial for conducted dilations irrespective of hypertension. Hypertension. 2012;60:1422-1429.
19. Anghelina M, Moldovan L, Moldovan NI. Preferential activity of Tie2 promoter in arteriolar endothelium. J Cell Mol Med. 2005;9:113-121.
20. Masuda H, Kalka C, Takahashi T, et al. Estrogen-mediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis. Circ Res. 2007;101:598-606.
21. Sato TN, Qin Y, Kozak CA, Audus KL. Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc Natl Acad Sci U S A. 1993;90:9355-9358.
22. Schlaeger TM, Bartunkova S, Lawitts JA, Teichmann G, Risau W, Deutsch U, Sato TN. Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice. Proc Natl Acad Sci U S A. 1997;94:3058-3063.
23. Castrop H, Höcherl K, Kurtz A, Schweda F, Todorov V, Wagner C. Physiology of kidney renin. Physiol Rev. 2010;90:607-673.
24. Fuchs S, Germain S, Philippe J, Corvol P, Pinet F. Expression of renin in large arteries outside the kidney revealed by human renin promoter/LacZ transgenic mouse. Am J Pathol. 2002;161:717-725.
25. Germain S, Fuchs S, Philippe J, Corvol P, Pinet F. New elements in human renin promoter involved in cell-specific expression. Clin Exp Pharmacol Physiol. 2001;28:1056-1059.
26. Riechers A, Bosserhoff AK. Pitfalls in immunohistochemistry-a recent example. Int J Clin Exp Pathol. 2012;5:137-139.
27. Schnell U, Dijk F, Sjollema KA, Giepmans BN. Immunolabeling artifacts and the need for live-cell imaging. Nat Methods. 2012;9:152-158.
28. Turlo KA, Gallaher SD, Vora R, Laski FA, Iruela-Arispe ML. When Cre-mediated recombination in mice does not result in protein loss. Genetics. 2010;186:959-967.
29. Hanstein R, Negoro H, Patel NK, Charollais A, Meda P, Spray DC, Suadicani SO, Scemes E. Promises and pitfalls of a Pannexin1 transgenic mouse line. Front Pharmacol. 2013;4:61.
30. Haefliger JA, Bergonzelli G, Waeber G, Aubert JF, Nussberger J, Gavras H, Nicod P, Waeber B. Renin and angiotensin II receptor gene expression in kidneys of renal hypertensive rats. Hypertension. 1995;26:733-737.
31. Kurtz L, Janssen-Bienhold U, Kurtz A, Wagner C. Connexin expression in renin-producing cells. J Am Soc Nephrol. 2009;20:506-512.
32. Kurtz L, Schweda F, de Wit C, Kriz W, Witzgall R, Warth R, Sauter A, Kurtz A, Wagner C. Lack of connexin 40 causes displacement of reninproducing cells from afferent arterioles to the extraglomerular mesangium. J Am Soc Nephrol. 2007;18:1103-1111.
33. Figueroa XF, Paul DL, Simon AM, Goodenough DA, Day KH, Damon DN, Duling BR. Central role of connexin40 in the propagation of electrically activated vasodilation in mouse cremasteric arterioles in vivo. Circ Res. 2003;92:793-800.
34. Haefliger JA, Castillo E, Waeber G, Bergonzelli GE, Aubert JF, Sutter E, Nicod P, Waeber B, Meda P. Hypertension increases connexin43 in a tissue-specific manner. Circulation. 1997;95:1007-1014.
35. Simon AM, McWhorter AR. Decreased intercellular dye-transfer and downregulation of non-ablated connexins in aortic endothelium deficient in connexin37 or connexin40. J Cell Sci. 2003;116(Pt 11): 2223-2236.
36. de Wit C. Different pathways with distinct properties conduct dilations in the microcirculation in vivo. Cardiovasc Res. 2010;85:604-613.
37. Volpe M, Unger T. Plasma renin and cardiovascular risk: what is the evidence for an association? Cardiology. 2013;125:50-59.
38. Chaston DJ, Baillie BK, Grayson TH, Courjaret RJ, Heisler JM, Lau KA, Machaca K, Nicholson BJ, Ashton A, Matthaei KI, Hill CE. Polymorphism in endothelial connexin40 enhances sensitivity to intraluminal pressure and increases arterial stiffness. Arterioscler Thromb Vasc Biol. 2013;33:962-970.
39. Lübkemeier I, Machura K, Kurtz L, Neubauer B, Dobrowolski R, Schweda F, Wagner C, Willecke K, Kurtz A. The connexin 40 A96S mutation causes renin-dependent hypertension. J Am Soc Nephrol. 2011;22:1031-1040.
40. Pfenniger A, van der Laan SW, Foglia B, Dunoyer-Geindre S, Haefliger JA, Winnik S, Mach F, Pasterkamp G, James RW, Kwak BR. Lack of association between connexin40 polymorphisms and coronary artery disease. Atherosclerosis. 2012;222:148-153.